Name
warf1
Label
Oral anticoagulants including warfarin, coumadin, and anisindione (Sleep Heart Health Study Visit One (SHHS1))
Description

Participant taking ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Oral anticoagulants including warfarin, coumadin, and anisindione (Sleep Heart Health Study Visit One (SHHS1)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total 5,804 - - -
No 5,653 - - -
Yes 133 - - -
Unknown 18 - - -
Oral anticoagulants including warfarin, coumadin, and anisindione (Sleep Heart Health Study Visit One (SHHS1)) vs Age at Sleep Heart Health Study Visit One (SHHS1)
Visit 1
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 342 1,017 1,769 1,617 955 104 5,804
No 333 1,011 1,752 1,558 899 100 5,653
Yes 3 2 14 57 53 4 133
Unknown 6 4 3 2 3 - 18
Oral anticoagulants including warfarin, coumadin, and anisindione (Sleep Heart Health Study Visit One (SHHS1)) vs Gender of the participant
Visit 1
Male Female Total
Total 2,765 3,039 5,804
No 2,669 2,984 5,653
Yes 85 48 133
Unknown 11 7 18
Oral anticoagulants including warfarin, coumadin, and anisindione (Sleep Heart Health Study Visit One (SHHS1)) vs Race of the participant
Visit 1
White Black Other Total
Total 4,907 515 382 5,804
No 4,776 503 374 5,653
Yes 121 7 5 133
Unknown 10 5 3 18